Higher levels of expression of IL-7R are associated with non-responsiveness to anti-TNF therapy in IBD and hence, higher inflammatory burden (36), while CCL18 is a chemokine that induces differentiation of T-cells towards a ‘pro-tumour’ type macrophage and facilitates matrix remodelling and immune evasion (41, 42). Here, IL7R is linked to inflammatory bowel disease.